Cipla
From Wikipedia, the free encyclopedia
| CIPLA Limited | |
 |
|
| Type | |
|---|---|
| Founded | 1935 |
| Headquarters |  Mumbai, India |
| Key people | Y. K. Hamied (CMD), Chairman |
| Industry | Pharmaceuticals |
| Revenue |  Rs. 24.8 billion (2005) |
| Net income | Rs. 4.1 billion (2005) |
| Employees | ??? |
| Website | www.cipla.com |
Cipla founded as The Chemical, Industrial & Pharmaceutical Laboratories is an Indian pharmaceutical company, best-known for manufacturing economical anti-AIDS drugs. The company was founded in 1935 by Khwaja Abdul Hamied, and is today run by Yusuf Hamied.
Cipla ignores the patents on these drugs, but no Indian law is broken in the process. With Cipla drugs, the cost of treating an AIDS patient has been reduced from $12,000 to $300 per year, still out of reach for most Indians. The customary treatment of AIDS consists of a cocktail of three drugs. Cipla produces an all-in-one pill called Triomune which contains all three substances (Lamivudine, stavudine and Nevirapine), something difficult elsewhere because the three patents are held by different companies. One more popular fixed dose combination is there, with the name Duovir-N. This contains Lamivudine, Zidovudine and Nevirapine.
[edit] External links
This Indian corporation, company, Cooperative, NGO or Public Sector Undertaking article is a stub. You can help Wikipedia by expanding it. |
This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
